Pharmabilast oral

Product Description

Pharmabilast 2.5 mg/ml oral solution

Each ml of oral solution contains 2.5 mg of bilastine.

Excipients with known effect: methyl parahydroxybenzoate, propyl parahydroxybenzoate
For the full list of excipients, see section 6.1.
PHARMACEUTICAL FORM

Oral Solution.

Clear Colourless homogenous oral solution with characteristic odour

CLINICAL PARTICULARS

Therapeutic Indications

Symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria. Pharmabilast is indicated in children aged 6 to 11 years with a body weight of at least 20 kg.